175 related articles for article (PubMed ID: 34421141)
1. ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment.
Turan S; Ermiş Ç; Pereira-Sanchez V; Tunctürk M; Pekcanlar AA
Psychopharmacol Bull; 2021 Jun; 51(3):10-26. PubMed ID: 34421141
[TBL] [Abstract][Full Text] [Related]
2. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
Moungnoi P; Maipang P
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
[TBL] [Abstract][Full Text] [Related]
4. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.
Germinario EA; Arcieri R; Bonati M; Zuddas A; Masi G; Vella S; Chiarotti F; Panei P;
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):440-7. PubMed ID: 24024538
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate and atomoxetine treatment negatively affect physical growth indexes of school-age children and adolescents with attention-deficit/hyperactivity disorder.
Deng L; Zhou P; Zhu L; Zhang Y; Yang T; Zhao Q; Chen J; Li T; Cheng Q; Chen L
Pharmacol Biochem Behav; 2021 Sep; 208():173225. PubMed ID: 34217783
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Koonrungsesomboon K; Koonrungsesomboon N
J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):189-197. PubMed ID: 31841645
[No Abstract] [Full Text] [Related]
8. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
9. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.
Kim HW; Kim SO; Shon S; Lee JS; Lee HJ; Choi JH
J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):448-53. PubMed ID: 25285915
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
McCarthy S; Neubert A; Man KKC; Banaschewski T; Buitelaar J; Carucci S; Coghill D; Danckaerts M; Falissard B; Garas P; Häge A; Hollis C; Inglis S; Kovshoff H; Liddle E; Mechler K; Nagy P; Rosenthal E; Schlack R; Sonuga-Barke E; Zuddas A; Wong ICK
BMC Psychiatry; 2018 Oct; 18(1):327. PubMed ID: 30305167
[TBL] [Abstract][Full Text] [Related]
11. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.
Pliszka SR; Matthews TL; Braslow KJ; Watson MA
J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):520-526. PubMed ID: 16670648
[TBL] [Abstract][Full Text] [Related]
13. Levels of Proneness to Boredom in Children with Attention-Deficit/Hyperactivity Disorder On and Off Methylphenidate Treatment.
Golubchik P; Manor I; Shoval G; Weizman A
J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):173-176. PubMed ID: 32031873
[No Abstract] [Full Text] [Related]
14. Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.
Chou WJ; Chen SJ; Chen YS; Liang HY; Lin CC; Tang CS; Huang YS; Yeh CB; Chou MC; Lin DY; Hou PH; Wu YY; Liu HJ; Huang YF; Hwang KL; Chan CH; Pan CH; Chang HL; Huang CF; Hsu JW
J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):215-25. PubMed ID: 22537358
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
16. The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Storebø OJ; Faltinsen E; Zwi M; Simonsen E; Gluud C
Clin Pharmacol Ther; 2018 Oct; 104(4):606-609. PubMed ID: 30006934
[TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
18. [Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder].
Zhang HY; Du ML; Zhuang SQ; Liu MN
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):723-7. PubMed ID: 16255846
[TBL] [Abstract][Full Text] [Related]
19. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.
Riggs PD; Winhusen T; Davies RD; Leimberger JD; Mikulich-Gilbertson S; Klein C; Macdonald M; Lohman M; Bailey GL; Haynes L; Jaffee WB; Haminton N; Hodgkins C; Whitmore E; Trello-Rishel K; Tamm L; Acosta MC; Royer-Malvestuto C; Subramaniam G; Fishman M; Holmes BW; Kaye ME; Vargo MA; Woody GE; Nunes EV; Liu D
J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):903-14. PubMed ID: 21871372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
